henhaobio
Sign in

Scientific ReportsMolecular BiologyPeer-reviewed journal article

Stress-induced phospho-ubiquitin formation causes parkin degradation

Lyudmila KovalchukeiD, Eugene V. MosharoviD, Oren A. LevyiD, Lloyd A. GreeneiD

PDFDOIPreprint

Abstract

Mutations in the E3 ubiquitin ligase parkin are the most common known cause of autosomal recessive parkinsonism. Multiple types of stress decrease parkin protein levels, an effect that may be relevant to sporadic Parkinsons disease (PD), but the mechanism(s) involved in this loss remain largely unclear. We sought to elucidate these mechanisms using a PD-relevant stressor, L-DOPA, the precursor to dopamine, which forms reactive oxygen species (ROS) as well as toxic quinones via auto-oxidation. We find that L-DOPA causes parkin loss through both an oxidative stress-independent and an oxidative stress-dependent pathway. Characterization of the latter reveals that it requires both the kinase PINK1 and parkins interaction with phosphorylated ubiquitin (phospho-Ub) and is mediated by proteasomal degradation.\n\nSurprisingly, mitochondrial parkin activity and autoubiquitination as well as mitophagy are not required for such loss. During stress induced by the oxidative stressor hydrogen peroxide or the metabolic uncoupler CCCP, parkin degradation also requires its association with phospho-Ub, indicating that this mechanism is broadly generalizable. As oxidative stress, metabolic dysfunction and phospho-Ub levels are all elevated in PD patients, we suggest that these changes may lead to the loss of parkin expression in PD.

Citations
15
FWCI
1.18
Field percentile
top 23%

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISPark '26Tokarew '21Lechado‐Ter '25Okarmus '22Agostini '26Keeney '21
72% semantic matchCell Biology
Chul Hong Park, Donghyuk Shin, Kwang Chul Chung·Journal of Cellular and Molecular Medicine·Apr 1, 2026